Middlefield Healthcare Dividend ETF
LS.TO
Toronto Stock Exchange- -
CAD
- -
- -
- -
- -
(- -)
Recent
price
- -
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Middlefield Healthcare Dividend ETF (TSX: MHCD), previously known under the ticker LS.TO, is an actively managed exchange-traded fund that provides investors with stable monthly cash distributions and enhanced long-term total return through capital appreciation by investing primarily in dividend-paying securities of issuers operating in or deriving significant revenue from the healthcare, life sciences, and biotechnology industries. The fund offers exposure to a diversified portfolio concentrated in pharmaceuticals (37.30%); health care equipment (19.50%); biotechnology (19.30%); life sciences tools and services (8.50%); health care facilities (4.90%); health care distributors (4.30%); managed health care (3.50%); and health care services (1.80%), with top holdings including Eli Lilly & Co. (7.60%), AstraZeneca PLC (6.10%), Johnson & Johnson (5.60%), AbbVie Inc. (4.60%), and Thermo Fisher Scientific Inc. (4.50%) as of November 30, 2025. Geographically, the fund allocates approximately 79.80% to the U.S., 15.30% to international markets including Europe and Asia, and 4.90% to Canada, targeting institutional and retail investors seeking income and growth in the global healthcare sector. Managed by Middlefield Limited, a specialist equity income asset manager founded in 1979 with headquarters in Toronto, Canada, and an additional office in London, England, the ETF was incepted on July 21, 2017, lists on the Toronto Stock Exchange, and features a management expense ratio of 1.25% with a management fee of 0.85%. Middlefield Limited serves as both portfolio manager and fund manager, with RBC Investor Services Trust (Canada) as custodian and TSX Trust Company as registrar; the fund supports a distribution reinvestment plan for commission-free compounding. In recent developments, the fund maintained its consistent monthly distribution of $0.05 per trust unit through 2025, with payments announced for the fourth quarter on October 24, 2025, covering record dates of October 31, November 30, and December 31, 2025. As of August 31, 2025, assets under management stood at approximately CAD 140 million, reflecting ongoing active management amid sector volatility, with no reported mergers, acquisitions, or major strategic shifts in the past 1-2 years beyond routine distribution announcements and portfolio rebalancing to capitalize on healthcare demographics including aging populations and rising chronic illness treatments.